Sign up to save your podcasts
Or
Share Adjuvant EGFR TKI Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Current and Future Perspectives
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Adjuvant EGFR TKI Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Current and Future Perspectives
Faculty panel moderated by Dr. Daniel Tan discusses the latest data on adjuvant use of EGFR TKIs in early-stage NSCLC.
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/940688?src=mkm_podcast_addon_940688
View all episodes
By Medscape Podcasts
4
77 ratings
Faculty panel moderated by Dr. Daniel Tan discusses the latest data on adjuvant use of EGFR TKIs in early-stage NSCLC.
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/940688?src=mkm_podcast_addon_940688
More shows like Keeping Current
View all
JAMA Editors' Summary
136 Listeners
NEJM This Week
320 Listeners
JAMA Clinical Reviews
496 Listeners
Diabetes Core Update
101 Listeners
This Week in Cardiology
886 Listeners
The Bob Harrington Show
13 Listeners
One-on-One with Eric Topol
17 Listeners
Mayo Clinic Talks
288 Listeners
The Curbsiders Internal Medicine Podcast
3,342 Listeners
Core IM | Internal Medicine Podcast
1,155 Listeners
Annals On Call Podcast
194 Listeners
JAMA Medical News
85 Listeners
The Clinical Problem Solvers
511 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
365 Listeners
Medicine and the Machine
61 Listeners
Keeping Current CME
24 Listeners
Cardionerds: A Cardiology Podcast
432 Listeners
The Curious Clinicians
370 Listeners